Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile. Shouval R, Goldman A, Flynn JR, El-Moghraby A, et al. Br J Haematol 2024;205:978-989.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shouval R, Goldman A, Flynn JR, El-Moghraby A, et al. Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile. Br J Haematol 2024;205:978-989.
PMID: 38735683